Position in UTHR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,814,919
-$2,540,762 QoQ
Shares Held
10,732
-23.8% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.84%
of 13F equity value
Holder Rank
#229
of 870 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026L2 Asset Management, LLC holds $8,599,935 across 3 Drug Manufacturers - Specialty & Generic names. UTHR ranks #1 (67.6% of the industry book) .
All Filings in UTHR
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,814,919 | 10,732 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $8,355,681 | 14,091 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,841,640 | 11,989 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,004,344 | 14,323 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,570,345 | 8,945 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,284,028 | 13,897 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,437,668 | 12,577 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,586,008 | 10,007 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $753,052 | 2,364 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $474,142 | 2,064 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $436,481 | 1,985 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $130,778 | 579 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,652,752 | 12,017 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,341,277 | 10,454 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,945,529 | 10,592 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,215,031 | 10,579 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||